New drug - Volibris
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Opinion
It's time to get involved in LMC representation
06-Jun-08
Your story, 'Rift fears for partners and salaried GPs', which featured the results of our diversity report was useful but only featured some of the issues (GP, 23 May).
In London we are determined to address solutions in terms of LMC representation. It's LMC election year and our 'Make your voice heard' campaign is encouraging all GPs, irrespective of their sex, age, race, ethnicity, disability, sexual orientation or contractual status to get informed, get involved and get taken seriously. Only by tackling difficult issues head on can we ensure LMCs continue to attract new blood.
Never before have LMCs and their constituents needed to act as urgently as now. The future of modern general practice depends upon it.
Dr Stewart M Drage, joint chief executive, Londonwide LMCs.
Tools
Healthcare Republic Forums
Hottest Topics
MIMS Product News
New drug - Thymoglobuline
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
New drug - Tyverb
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Jobs
Job of the Week
- Locum GPs wanted North East England
- Salaried GP South East England
- Health Assessment Doctors None Specified
- GP - Australia Australasia
- Part Time Salaried GP North East England
- Salaried GP East Midlands
- GPs wanted for New Zealand Other International
- Replacement Full Time Partner and Full Time Salaried Doctor North West England
- Full time salaried GP North West England
- Salaried GP Yorkshire and Humberside
Comments
Only registered users may comment. Log in now or register for a free account.